Ctc Alternative Strategies, Ltd. Ginkgo Bioworks Holdings, Inc. Transaction History
Ctc Alternative Strategies, Ltd.
- $236 Billion
- Q2 2024
A detailed history of Ctc Alternative Strategies, Ltd. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Ctc Alternative Strategies, Ltd. holds 169,298 shares of DNA stock, worth $1.31 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
169,298Holding current value
$1.31 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding DNA
# of Institutions
248Shares Held
887MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.11 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.08 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.04 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$541 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$326 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $9.98B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...